AUVI - Applied UV appoints new CEO
Applied UV (AUVI -2.0%) appoints James Alecxih as CEO and as a member of the company's Board of Directors, effective December 8, 2021. The appointment follows the resignation of Keyoumars Saeed, who served as CEO since June 30, 2020, prior to the company's initial public offering on August 31, 2020. Mr. Saeed will serve as a consultant to the company for up to six months, with a primary focus on evaluating potential synergistic acquisitions. Prior to joining the company, Mr. Alecxih was President and CEO of Vivebio Scientific, developer of a proprietary vertical flow dried plasma separation device that enables high volume viral load testing, lipid panels and mass spectrometry.
For further details see:
Applied UV appoints new CEO